(S)-2-(Boc-Amino)non-8-Enoic Acid CAS 300831-21-4 Ucoceko >98.0% (GC) ee >99.0% Paritaprevir Intermediate Factory Featured Image

(S)-2-(Boc-Amino)non-8-Enoic Acid CAS 300831-21-4 Ubunyulu>98.0% (GC) ee>99.0% Paritaprevir Intermediate Factory

Inkcazelo emfutshane:

Igama: (S)-2-(Boc-Amino)non-8-Enoic Acid

CAS: 300831-21-4

Ubunyulu: >98.0% (GC)

ee: >99.0%

Imbonakalo: Ulwelo oluBrown

Abaphakathi beParitaprevir (CAS: 1216941-48-8)

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-2-(Boc-Amino)non-8-Enoic Acid (CAS: 300831-21-4) with high quality, commercial production. Ruifu Chemical offers a wide range of chiral compounds. We can provide Certificate of Analysis (COA), worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Iipropati zeMichiza:

Igama leMchiza	(S) -2-(Boc-Amino) non-8-Enoic Acid
Izithethantonye	(S)-2-(tert-Butoxycarbonylamino)non-8-Enoic Acid;(S) -2-(Boc-Amino)-8-Nonenoic Acid;(2S)-2-[(2-Methylpropan-2-yl)oxycarbonylamino]non-8-Enoic Acid;(2S)-2-{[(tert-Butoxy)carbonyl]amino}non-8-Enoic Acid
Inombolo yeCAS	300831-21-4
Inombolo yeCAT	RF-CC347
Ubume beStokhwe	Ikhona evenkileni
Ifomula yeemolekyuli	C14H25NO4
Ubunzima beMolekyuli	271.35
Ukuxinana	1.035±0.06 g/cm3
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Ulwelo oluBrown
Ubunyulu / Indlela yokuHlalutya	>98.0% (GC)
ee	>99.0%
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	Abaphakathi beParitaprevir (CAS: 1216941-48-8)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile eneFluorinated, 25kg/Drum, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

FAQ:

Isicelo:

(S) -2- (Boc-Amino) non-8-Enoic Acid (CAS: 300831-21-4) ingasetyenziselwa njengendawo ephakathi kwi-synthesis yeParitaprevir (CAS: 1216941-48-8) kunye ne-analogs ehambelanayo.I-Paritaprevir isizukulwana sesibini se-NS3/4A protease inhibitor, yinxalenye yonyango oludibeneyo lwentsholongwane yomlomo, i-interferon-free hepatitis C ephuhliswe yi-Enanta Pharmaceuticals kunye ne-AbbVie.Ipilisi yedosi emiselweyo yeParitaprevir, Ombitasvir kunye neRitonavir ethathwe kunye neDasabuvir yamkelwa kunyango lwe-HCV engapheliyo genotype 1 e-USA kunye ne-EU ngo-2014, kwaye yamkelwe ngakumbi unyango lwe-genotype 4 usulelo olungapheliyo lwe-HCV ngaphandle kwe-cirrhosis yi-US. I-FDA kwi-2015.